TRUPANION INC
TRUPNASDAQTrading Snapshot
- Day Range
- $30.26 – $31.02
- 52-Week Range
- $21.16 – $57.00
- Volume
- $2.11B
- Avg Volume
- $1.45B
- Shares Outstanding
- 43.6M
- Next Earnings
- Sep 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.44B
- Last Q Revenue
- $393M
- P/E Ratio
- 54.7
- P/S Ratio
- 0.8x
- EPS (TTM)
- $0.53
- Dividend Yield
- —
Why Investors Own TRUP
- ✓High-growth profile — revenue up -4.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 46% gross margin and 10% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About TRUPANION INC
Trupanion, Inc. provides monthly subscription-based medical insurance for canine and feline companions across the United States, Canada, Puerto Rico, and Australia. The company's operations are divided into two main categories: Subscription Business and Other Business, serving both pet owners and veterinary professionals. Founded in 2000, the Seattle, Washington-headquartered firm was previously known as Vetinsurance International, Inc., before adopting the Trupanion, Inc. name in 2013.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Trupanion, Inc. (TRUP) Q2 2026 Earnings Call Transcript
Trupanion, Inc. (TRUP) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsGil Melchior - Director of Investor RelationsMargaret Tooth -...
Trupanion (NASDAQ:TRUP) Rises After Q2 Earnings Beat and Buyback Program Announcement
Trupanion Q2 EPS beats at $0.16, revenue slightly misses at $392.9M, shares rise 2.9% after buyback authorization.
Trupanion Sees Q3 Sales $399.000M-$405.000M vs $398.218M Est
Trupanion (NASDAQ:TRUP) sees Q3 sales of $399.000 million-$405.000 million vs $398.218 million analyst estimate.
Trupanion Raises FY2026 Sales Guidance from $1.556B-$1.581B to $1.584B-$1.601B vs $1.579B Est
Trupanion (NASDAQ:TRUP) raises FY2026 sales outlook from $1.556 billion-$1.581 billion to $1.584 billion-$1.601 billion vs $1.579 billion estimate.
Trupanion Announces $100M Buyback Plan
Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced its Board has authorized a share repurchase program, pursuant to which the Company may repurchase up to an
Trupanion Q2 EPS $0.16 Beats $0.12 Estimate, Sales $392.900M Beat $389.710M Estimate
Trupanion (NASDAQ:TRUP) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.12 by 33.33 percent. This is a 27.27 percent decrease over earnings of $0.22 per share from the same